590 F.Supp.3d 738
D. Del.2022Background
- Plaintiff Robert Garner bought a Global Plasma "bipolar ionization" air ionizer during the COVID-19 pandemic after marketing representations that it would improve air quality and help protect against COVID-19.
- Scientific literature and third‑party studies cited in the complaint show mixed results on bipolar ionization’s effectiveness against small compounds, surface disinfection, and airborne viruses.
- Garner filed a putative class action asserting fraudulent misrepresentation, fraudulent concealment, Maryland consumer‑protection violations, breach of express and implied warranties, unjust enrichment, and Magnuson‑Moss Act violations; he seeks damages and restitution (he withdrew injunctive relief).
- Global Plasma moved to dismiss for lack of standing and failure to state claims; the court found standing adequate for Garner (including as to a multistate class at this stage) but dismissed most claims on the merits.
- The court allowed Garner’s fraudulent‑misrepresentation claim to proceed (identifying plausible misrepresentations about “independent” testing, the absence of harmful byproducts, and being a “proven” tool against COVID), but dismissed fraudulent concealment, the Maryland consumer‑protection claim, unjust enrichment, warranty claims (for failure to plead pre‑suit notice), and the Magnuson‑Moss claim (federal rule requires 100 named plaintiffs for a class claim).
- The court gave Garner leave to amend the dismissed claims where defects were curable (e.g., pleading home use to satisfy the Maryland consumer‑goods element or attaching notice documents for warranty claims).
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Standing — individual injury | Garner relied on marketing and lost money buying ionizer he expected to cleanse air/protect from COVID | No cognizable injury for damages/restitution | Held: Garner has standing; expectation that product would work suffices |
| Standing — multistate class | May represent buyers in multiple states; injury exists irrespective of recoverability under other states’ laws | Multistate claims require plaintiff residency or defeat standing | Held: Permissible at pleading stage; choice‑of‑law/class‑cert issues for certification, not standing |
| Standing — plaintiffs who didn’t buy certain models | Can represent purchasers of related Global Plasma ionizers because claims focus on common bipolar‑ionization tech | Plaintiff lacks personal injury as to unpurchased models | Held: Claims about other ionizers not dismissed at this stage; similarity is a certification issue |
| Fraudulent misrepresentation (Rule 9(b)) | Identifies numerous specific marketing statements and says he read them and relied on them | Statements are puffery, nonactionable, or accompanied by disclaimers; reliance not pleaded | Held: Some statements actionable (independent testing, no harmful byproducts, “proven” vs COVID); pleading of reliance adequate; misrepresentation claim survives |
| Fraudulent concealment | Defendant concealed unfavorable facts and sued critics to silence them | No affirmative concealment alleged; lawsuits of record don’t conceal | Held: Dismissed for failure to plead affirmative concealment |
| Maryland consumer‑protection statute | Marketing was deceptive; Garner is a consumer and suffered injury | Ionizer is not necessarily a "consumer good" and Garner did not allege home use | Held: Dismissed; plaintiff must plead intent to use as a consumer (e.g., home use) to proceed |
| Unjust enrichment | Retention of plaintiff’s purchase price by Global Plasma made retention unconscionable | Plaintiff bought from third‑party retailer; no allegation funds reached defendant | Held: Dismissed for failure to allege defendant received plaintiff’s money |
| Breach of warranty (express/implied) | Product did not conform to promises; legal warranty claims stated | Plaintiff failed to plead pre‑suit notice and description of nonconformity | Held: Dismissed; complaint must allege adequate pre‑suit notice (may amend) |
| Magnuson‑Moss Act | Federal warranty claim and class relief available | Magnuson‑Moss requires 100 named plaintiffs for federal class actions | Held: Dismissed (only one named plaintiff here) |
Key Cases Cited
- In re Johnson & Johnson Talcum Powder Prods. Marketing, Sales Practices & Liability Litig., 903 F.3d 278 (3d Cir. 2018) (expectation of product performance can support standing)
- Sierra Club v. Morton, 405 U.S. 727 (U.S. 1972) (standing requires injury in fact)
- Morrison v. YTB Int’l, Inc., 649 F.3d 533 (7th Cir. 2011) (distinguishing standing from class‑certification issues)
- FTC v. Roca Labs, Inc., 345 F. Supp. 3d 1375 (M.D. Fla. 2018) (disclosure of sponsored testing and testimonial practices relevant to deception)
- EP Medsystems, Inc. v. EchoCath, Inc., 235 F.3d 865 (3d Cir. 2001) (disclaimers must be tailored to the misstatement to negate reliance)
- Doll v. Ford Motor Co., 814 F. Supp. 2d 526 (D. Md. 2011) (pre‑suit warranty‑notice requirements and specificity)
- Bank of Am. Corp. v. Gibbons, 918 A.2d 565 (Md. Ct. Spec. App. 2007) (elements of unjust enrichment require defendant received plaintiff’s money)
- In re Burlington Coat Factory Sec. Litig., 114 F.3d 1410 (3d Cir. 1997) (limits on considering documents outside the complaint)
- Daubert v. Merrell Dow Pharms., 509 U.S. 579 (U.S. 1993) (scientific disputes and admissibility for later stages)